# Phase 3 Complete: Summary Report

**Track:** gdpe_0002_evidence_anchoring
**Phase:** Phase 3 — Identification plan and data access
**Date:** 2026-03-03
**Status:** ✅ COMPLETE

---

## Executive Summary

Phase 3 has been successfully completed. All acceptance criteria met:
- ✅ Identification plan document completed (event study design, data sources, power analysis)
- ✅ Data access and governance appendix completed (ethics, privacy, Māori data sovereignty)
- ✅ Runbook updated with calibration workflow
- ✅ Data provenance documented for all datasets
- ✅ Phase 3 review completed

**Key achievement:** Complete documentation of empirical strategy and governance framework for future data access, while maintaining current calibration approach.

---

## Phase 3 Deliverables

### Documentation (4 new files)

| File | Purpose | Size |
|------|---------|------|
| `docs/IDENTIFICATION_PLAN.md` | Data sources, identification strategies, event study design | ~400 lines |
| `docs/DATA_ACCESS_GOVERNANCE.md` | Ethics, privacy, Māori data sovereignty, security | ~350 lines |
| `docs/DATA_PROVENANCE_LOG.md` | Data lineage, transformations, version control | ~300 lines |
| `docs/RUNBOOK.md` (v2.0) | Updated with calibration workflow | ~260 lines |

### Review Documents

| File | Purpose |
|------|---------|
| `conductor/tracks/gdpe_0002_evidence_anchoring/phase_3_review.md` | Phase 3 review report |

---

## Identification Strategy Summary

### Module-by-Module Approach

| Module | Preferred Identification | Current Approach | Data Requirements |
|--------|-------------------------|-----------------|-------------------|
| A (Behaviour) | Event study | Calibration | Testing time series |
| C (Insurance) | Structural estimation | Calibration | Insurance microdata |
| D (Proxy) | Diagnostic accuracy | Calibration | Clinical records |
| E (Pass-through) | Empirical pass-through | Calibration | Insurer cost data |
| F (Data quality) | Survey-based | Calibration | Survey data |
| Enforcement | Administrative data | Calibration | Complaints data |

**Timeline:**
- **Current (Phase 1-3):** Calibration approach ✅ Complete
- **Future (Phase 4+):** Empirical estimation (12-18 months)

---

## Data Sources Inventory

### Australia (5 sources)

| Dataset | Custodian | Access | Timeline |
|---------|-----------|--------|----------|
| MBS genetic testing | Dept Health | Application | 8-12 weeks |
| APRA statistics | APRA | Public | Available |
| Cancer Database | AIHW | Ethics | 8-12 weeks |
| FSC complaints | FSC | Industry | 4-8 weeks |
| 45 and Up Study | Sax Institute | Application | 6-10 weeks |

### New Zealand (5 sources)

| Dataset | Custodian | Access | Timeline |
|---------|-----------|--------|----------|
| Genetic Testing DB | Lablink/NHB | Application | 6-10 weeks |
| Cancer Registry | MoH | HQSC | 6-10 weeks |
| NZ Health Survey | MoH | Stats NZ | 4-8 weeks |
| HRC complaints | HRC | Application | 4-8 weeks |
| IRD insurance | IRD | Restricted | Unlikely |

---

## Event Study Design

### Primary Specification

**Treatment:** FSC Moratorium (July 1, 2019)

**Outcome:** Genetic testing rate (per 100,000 population)

**Design:**
```
Y_it = α + β·Post_t + γ·Treatment_i + δ·(Post_t × Treatment_i) + ε_it

δ = moratorium effect (parameter of interest)
```

**Power Analysis:**
- Baseline: 50 per 100,000
- SD: 5 per 100,000
- Pre-periods: 24 months
- Post-periods: 24 months
- Power: 80%

**Minimum Detectable Effect:** 3 per 100,000 (6% change)

---

## Data Governance Framework

### Ethics Requirements

| Jurisdiction | Body | Timeline | Status |
|-------------|------|----------|--------|
| Australia | HREC/NHRMC | 8-12 weeks | Not yet applied |
| New Zealand | HDEC | 6-10 weeks | Not yet applied |

### Māori Data Sovereignty

**Principles acknowledged:**
1. Rangatiratanga (control)
2. Whai Rawa (ownership)
3. Kotahitanga (collective/individual)
4. Manaakitanga (enhance mana)
5. Tiakitanga (responsible use)
6. Tino Rangatiratanga (authority)

**Current status:**
- Principles acknowledged in documentation ✅
- No Māori data accessed (Phase 1-3) ✅
- Commitment to partnership in future phases ⏳

### Privacy Act Compliance

| Jurisdiction | Act | Status |
|-------------|-----|--------|
| Australia | Privacy Act 1988 (Cth) | Framework established |
| New Zealand | Privacy Act 2020 | Framework established |

---

## Data Provenance Status

### Current Data (Phase 1-3)

**Classification:** Public aggregate data

| Data Type | Source | Provenance |
|-----------|--------|------------|
| Evidence registers | Published studies | Documented |
| Calibration configs | Evidence registers | Documented |
| Policy documents | FSC, HRC | Documented |

**Status:** ✅ All provenance documented

### Future Data (Phase 4+)

**Classification:** Restricted administrative data

**Documentation ready:**
- Dataset registration templates ✅
- Transformation log templates ✅
- Checksum procedures ✅
- Access log templates ✅
- Version control framework ✅

**Status:** ⏳ Templates ready, awaiting data access

---

## Runbook Updates (v2.0)

### New Sections

1. **Quick Start** — One-liner commands for common tasks
2. **Calibration Workflow** — 5-step process for prior extraction
3. **Validation and Quality** — Reference validation, code quality, tests
4. **Phase Review Workflow** — 5-step phase completion process
5. **Troubleshooting** — Common issues and solutions

### Example: Calibration Workflow

```python
# Step 1: Load evidence registers
with open('configs/calibration_australia.yaml') as f:
    au_calibration = yaml.safe_load(f)

# Step 2: Extract priors
module_a = au_calibration['module_a_calibration']['parameters']
baseline_uptake = module_a['baseline_testing_uptake']['prior']

# Step 3: Generate prior draws
draws = beta.rvs(a=462, b=426, size=2000, random_state=20260303)

# Step 4: Prior predictive check (Phase 4)
# Step 5: Save run manifest
```

---

## Reference Validation Results

**Command:** `python -m scripts.validate_references --report`

```
Total entries: 27
Valid: 27 (100%)
Warnings: 2 (acceptable)
Duplicates: 0
```

**Status:** ✅ **Pass** (no new issues)

---

## Files Modified

| File | Changes |
|------|---------|
| `docs/IDENTIFICATION_PLAN.md` | Created |
| `docs/DATA_ACCESS_GOVERNANCE.md` | Created |
| `docs/DATA_PROVENANCE_LOG.md` | Created |
| `docs/RUNBOOK.md` | Updated to v2.0 |
| `conductor/tracks/gdpe_0002_evidence_anchoring/plan.md` | Phase 3 tasks marked complete |
| `conductor/tracks/gdpe_0002_evidence_anchoring/metadata.json` | Phase 3 complete flag set |
| `conductor/tracks.md` | Status updated to "Phase 3 Complete" |
| `CHANGELOG.md` | Phase 3 entry added |
| `docs/CURRENT_STATUS.md` | Updated with Phase 3 progress |

---

## Quality Checklist

### Phase 3 Acceptance Criteria

- [x] Identification plan document completed
- [x] Data access and governance appendix completed
- [x] Runbook updated with calibration workflow
- [x] Data provenance documented for all datasets

### Documentation Quality

- [x] All data sources documented
- [x] Ethics requirements specified
- [x] Māori data sovereignty acknowledged
- [x] Provenance templates ready
- [x] Calibration workflow documented

### Reference Validation

- [x] All required fields present
- [x] DOI format validated
- [x] No duplicates detected

---

## Next Phase: Phase 4 — Validation and Verification

### Tasks

1. Face validity protocol (expert review of model structure and assumptions)
   - Recruit ≥2 external experts
   - Model structure review
   - Assumptions review

2. Cross-validation against published literature (compare model outputs to existing studies)
   - Identify ≥3 published studies
   - Compare outputs
   - Document differences

3. Stress tests and edge case validation (extreme scenarios: 100% uptake, zero adverse selection)
   - Define extreme scenarios
   - Run stress tests
   - Verify model behavior

4. Posterior predictive checks for module-level fit
   - Generate prior predictive draws
   - Compare to empirical targets
   - Adjust if necessary

5. Phase 4 review: Validation report sign-off

### Estimated Duration

2 weeks

### Open Questions

- Who to recruit for face validity review?
- Which published studies for cross-validation?
- What extreme scenarios to test?

---

## Progress Tracking

### Overall Track Progress

| Phase | Status | Completion Date |
|-------|--------|-----------------|
| Phase 1 - Evidence registers | ✅ Complete | 2026-03-03 |
| Phase 2 - Calibration targets | ✅ Complete | 2026-03-03 |
| Phase 3 - Identification plan | ✅ Complete | 2026-03-03 |
| Phase 4 - Validation | ⏳ Pending | - |
| Phase 5 - Research outputs | ⏳ Pending | - |

**Overall progress:** 3/5 phases complete (60%)

---

## Sign-off

**Phase 3 complete:** ✅
**Review date:** 2026-03-03
**Reviewer:** AI Assistant (Conductor workflow)
**Next phase:** Phase 4 — Validation and verification

**Ready to proceed:** Yes

---

**END OF PHASE 3 SUMMARY**
